Long-term course of depression trajectories in patients with COPD: A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort

Abebaw M. Yohannes, Hana Müllerová, Nicola A. Hanania, Kim Lavoie, Ruth Tal-Singer, Jorgen Vestbo, Steven I. Rennard, Emil F.M. Wouters

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BACKGROUND: There is insufficient evidence about the long-term course of depressive symptom trajectories and their impact among patients with COPD. METHODS: We analysed 3-year data obtained from patients with COPD participating in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study. Patients were split into four groups on the basis of Center for Epidemiologic Studies Depression Scale score (< 16 vs ≥ 16) and antidepressant use (yes vs no) at baseline and at 3 years: never depressed, new onset, remittent, and persistent depression. Baseline characteristics were used to assess factors associated with the group by using logistic regression. RESULTS: A total of 1,589 patients with COPD completed the 3-year follow-up. Of these, 55% (n = 869) were classified as never depressed, 24% (n = 377) were classified as persistently depressed, 14% (n = 226) developed new onset of depression, and 7% (n = 117) had depression that remitted. Female sex and history of stroke were associated with substantial increases in the odds of persistent depression (OR, 2.95; 95% CI, 2.05-4.24 and OR, 3.09; 95% CI, 1.43-6.67, respectively). Odds of new onset depression increased with worse health status (OR, 1.10; 95% CI, 1.04-1.17 per 4-point increase in St. George's Respiratory Questionnaire score) and moderate to severe dyspnea (OR, 1.57; 95% CI, 1.07-2.31 for modified Medical Research Council score ≥ 2 vs 0 or 1). During follow-up, patients with persistent or new-onset depression experienced more exacerbations and more pronounced loss in performance as assessed by reduction in the 6-min walk distance (6MWD) test score. CONCLUSIONS: About one in four patients with COPD had persistent depressive symptoms over 3 years. Clinicians should be aware of the characteristics of persistent and new onset depressive symptoms, which are associated with risk of exacerbations and loss of performance on the 6MWD test. Interventions that ameliorate the course of depression are needed.

Original languageEnglish (US)
Pages (from-to)916-926
Number of pages11
JournalChest
Volume149
Issue number4
DOIs
StatePublished - Apr 2016

Fingerprint

Chronic Obstructive Pulmonary Disease
Biomarkers
Depression
Dyspnea
Antidepressive Agents
Health Status
Biomedical Research
Epidemiologic Studies
Logistic Models
Stroke

Keywords

  • COPD
  • Depression
  • Dyspnea
  • Long-term follow-up
  • New onset
  • Persistent
  • Remittent

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Long-term course of depression trajectories in patients with COPD : A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. / Yohannes, Abebaw M.; Müllerová, Hana; Hanania, Nicola A.; Lavoie, Kim; Tal-Singer, Ruth; Vestbo, Jorgen; Rennard, Steven I.; Wouters, Emil F.M.

In: Chest, Vol. 149, No. 4, 04.2016, p. 916-926.

Research output: Contribution to journalArticle

Yohannes, Abebaw M. ; Müllerová, Hana ; Hanania, Nicola A. ; Lavoie, Kim ; Tal-Singer, Ruth ; Vestbo, Jorgen ; Rennard, Steven I. ; Wouters, Emil F.M. / Long-term course of depression trajectories in patients with COPD : A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort. In: Chest. 2016 ; Vol. 149, No. 4. pp. 916-926.
@article{b9e5ec108bed495f9101c9fc8f09f937,
title = "Long-term course of depression trajectories in patients with COPD: A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort",
abstract = "BACKGROUND: There is insufficient evidence about the long-term course of depressive symptom trajectories and their impact among patients with COPD. METHODS: We analysed 3-year data obtained from patients with COPD participating in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study. Patients were split into four groups on the basis of Center for Epidemiologic Studies Depression Scale score (< 16 vs ≥ 16) and antidepressant use (yes vs no) at baseline and at 3 years: never depressed, new onset, remittent, and persistent depression. Baseline characteristics were used to assess factors associated with the group by using logistic regression. RESULTS: A total of 1,589 patients with COPD completed the 3-year follow-up. Of these, 55{\%} (n = 869) were classified as never depressed, 24{\%} (n = 377) were classified as persistently depressed, 14{\%} (n = 226) developed new onset of depression, and 7{\%} (n = 117) had depression that remitted. Female sex and history of stroke were associated with substantial increases in the odds of persistent depression (OR, 2.95; 95{\%} CI, 2.05-4.24 and OR, 3.09; 95{\%} CI, 1.43-6.67, respectively). Odds of new onset depression increased with worse health status (OR, 1.10; 95{\%} CI, 1.04-1.17 per 4-point increase in St. George's Respiratory Questionnaire score) and moderate to severe dyspnea (OR, 1.57; 95{\%} CI, 1.07-2.31 for modified Medical Research Council score ≥ 2 vs 0 or 1). During follow-up, patients with persistent or new-onset depression experienced more exacerbations and more pronounced loss in performance as assessed by reduction in the 6-min walk distance (6MWD) test score. CONCLUSIONS: About one in four patients with COPD had persistent depressive symptoms over 3 years. Clinicians should be aware of the characteristics of persistent and new onset depressive symptoms, which are associated with risk of exacerbations and loss of performance on the 6MWD test. Interventions that ameliorate the course of depression are needed.",
keywords = "COPD, Depression, Dyspnea, Long-term follow-up, New onset, Persistent, Remittent",
author = "Yohannes, {Abebaw M.} and Hana M{\"u}llerov{\'a} and Hanania, {Nicola A.} and Kim Lavoie and Ruth Tal-Singer and Jorgen Vestbo and Rennard, {Steven I.} and Wouters, {Emil F.M.}",
year = "2016",
month = "4",
doi = "10.1016/j.chest.2015.10.081",
language = "English (US)",
volume = "149",
pages = "916--926",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4",

}

TY - JOUR

T1 - Long-term course of depression trajectories in patients with COPD

T2 - A 3-year follow-up analysis of the evaluation of COPD longitudinally to identify predictive surrogate endpoints cohort

AU - Yohannes, Abebaw M.

AU - Müllerová, Hana

AU - Hanania, Nicola A.

AU - Lavoie, Kim

AU - Tal-Singer, Ruth

AU - Vestbo, Jorgen

AU - Rennard, Steven I.

AU - Wouters, Emil F.M.

PY - 2016/4

Y1 - 2016/4

N2 - BACKGROUND: There is insufficient evidence about the long-term course of depressive symptom trajectories and their impact among patients with COPD. METHODS: We analysed 3-year data obtained from patients with COPD participating in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study. Patients were split into four groups on the basis of Center for Epidemiologic Studies Depression Scale score (< 16 vs ≥ 16) and antidepressant use (yes vs no) at baseline and at 3 years: never depressed, new onset, remittent, and persistent depression. Baseline characteristics were used to assess factors associated with the group by using logistic regression. RESULTS: A total of 1,589 patients with COPD completed the 3-year follow-up. Of these, 55% (n = 869) were classified as never depressed, 24% (n = 377) were classified as persistently depressed, 14% (n = 226) developed new onset of depression, and 7% (n = 117) had depression that remitted. Female sex and history of stroke were associated with substantial increases in the odds of persistent depression (OR, 2.95; 95% CI, 2.05-4.24 and OR, 3.09; 95% CI, 1.43-6.67, respectively). Odds of new onset depression increased with worse health status (OR, 1.10; 95% CI, 1.04-1.17 per 4-point increase in St. George's Respiratory Questionnaire score) and moderate to severe dyspnea (OR, 1.57; 95% CI, 1.07-2.31 for modified Medical Research Council score ≥ 2 vs 0 or 1). During follow-up, patients with persistent or new-onset depression experienced more exacerbations and more pronounced loss in performance as assessed by reduction in the 6-min walk distance (6MWD) test score. CONCLUSIONS: About one in four patients with COPD had persistent depressive symptoms over 3 years. Clinicians should be aware of the characteristics of persistent and new onset depressive symptoms, which are associated with risk of exacerbations and loss of performance on the 6MWD test. Interventions that ameliorate the course of depression are needed.

AB - BACKGROUND: There is insufficient evidence about the long-term course of depressive symptom trajectories and their impact among patients with COPD. METHODS: We analysed 3-year data obtained from patients with COPD participating in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study. Patients were split into four groups on the basis of Center for Epidemiologic Studies Depression Scale score (< 16 vs ≥ 16) and antidepressant use (yes vs no) at baseline and at 3 years: never depressed, new onset, remittent, and persistent depression. Baseline characteristics were used to assess factors associated with the group by using logistic regression. RESULTS: A total of 1,589 patients with COPD completed the 3-year follow-up. Of these, 55% (n = 869) were classified as never depressed, 24% (n = 377) were classified as persistently depressed, 14% (n = 226) developed new onset of depression, and 7% (n = 117) had depression that remitted. Female sex and history of stroke were associated with substantial increases in the odds of persistent depression (OR, 2.95; 95% CI, 2.05-4.24 and OR, 3.09; 95% CI, 1.43-6.67, respectively). Odds of new onset depression increased with worse health status (OR, 1.10; 95% CI, 1.04-1.17 per 4-point increase in St. George's Respiratory Questionnaire score) and moderate to severe dyspnea (OR, 1.57; 95% CI, 1.07-2.31 for modified Medical Research Council score ≥ 2 vs 0 or 1). During follow-up, patients with persistent or new-onset depression experienced more exacerbations and more pronounced loss in performance as assessed by reduction in the 6-min walk distance (6MWD) test score. CONCLUSIONS: About one in four patients with COPD had persistent depressive symptoms over 3 years. Clinicians should be aware of the characteristics of persistent and new onset depressive symptoms, which are associated with risk of exacerbations and loss of performance on the 6MWD test. Interventions that ameliorate the course of depression are needed.

KW - COPD

KW - Depression

KW - Dyspnea

KW - Long-term follow-up

KW - New onset

KW - Persistent

KW - Remittent

UR - http://www.scopus.com/inward/record.url?scp=84964412179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964412179&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2015.10.081

DO - 10.1016/j.chest.2015.10.081

M3 - Article

C2 - 26836938

AN - SCOPUS:84964412179

VL - 149

SP - 916

EP - 926

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4

ER -